ghk cu safety ghk-cu injection clinical trial ghk-cu peptide dosage safety injection

For lawful laboratory and analytical use where permitted by law

CJC-1295 has been marketed with and without drug affinity complex (DAC) technology, which extends its half-life and resultant therapeutic window as follows [2]: CJC-1295 No DAC: CJC-1295 No DAC contains only straight CJC-1295 with a D-Ala at the 2-position, a Gln at the 8-position (to reduce asparagine rearrangement), an Ala at position 15 (to enhance bioactivity), and a Leu at position 27 (to prevent methionine oxidation)

(13) DSIP and Longevity A study (14) was conducted on murine models, equally divided into DSIP and control groups

And so its very important to get that process right so that youre not making scar tissue, number one, because scar tissue is bad because its not vascularized